Pagina de pornireABUS • NASDAQ
add
Arbutus Biopharma Corp
Închidere anterioară
4,26 $
Interval anual
2,71 $ - 5,10 $
Capitalizare bursieră
819,30 mil. USD
Volum mediu
2,67 mil.
Raport P/E
-
Randamentul dividendelor
-
Bursă principală
NASDAQ
La știri
Despre
Arbutus Biopharma Corporation is a publicly traded Canadian biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection.
It is headquartered in Warminster, Pennsylvania. The company was formerly known as Tekmira, which was spun out of Inex Pharmaceuticals in 2007. Wikipedia
Director executiv
Înființare
2007
Site
Angajați
44
